In vitro study shows linalool reduces Toxoplasma gondii mortality rates, suggesting it may warrant further safety investigations.
The flow cytometry results revealed a dose-dependent anti-Toxoplasma activity for linalool, with 18.37%, 36.77%, 38.75%, 47.57%, and 50.63% mortality rates at the concentrations of 37.5, 75, 150, 300, and 600 µg/mL, respectively. The mortality rate at the concentration of 1200 µg/mL (74.44%) was slightly higher than that of the positive control group (67.87%). Our findings provide primary evidence for the extracellular potential of linalool against T. gondii tachyzoites. This study provides a rationale for further research to evaluate linalool's intracellular and in vivo efficacy and safety.
No takes yet. Share an insight, caveat, or question.
Goudarzi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: